Literature DB >> 23706343

Experts and beginners benefit from three-dimensional echocardiography: a multicenter study on the assessment of mitral valve prolapse.

Maximilian Dominik Hien1, Manuel Großgasteiger, Helmut Rauch, Alexander Weymann, Raffi Bekeredjian, Christian Rosendal.   

Abstract

BACKGROUND: Three-dimensional (3D) transesophageal echocardiography (TEE) has been claimed to provide more information than two-dimensional (2D) TEE in the localization of mitral valve prolapse (MVP). However, most studies have been performed by experts in echocardiography, without accounting for differences in training or expertise. This multicenter study was designed to assess the differences between experts and inexperienced echocardiographers in localizing MVP and ruptured chordae tendineae using 2D and real-time 3D TEE.
METHODS: Thirty-six observers from 10 institutions in Germany and Switzerland interpreted 2D and 3D transesophageal echocardiographic images from six patients selected to represent a large spectrum of MVP diversity. Surgical findings served as a reference. Individual performance in the prediction of pathology was scored. Differences between 15 experts and 21 beginners in TEE were assessed, and the benefits conferred by 3D TEE were compared.
RESULTS: Both study groups scored significantly higher when interpreting 3D transesophageal echocardiographic images (P ≤ .001). The experts were superior in 2D MVP localization (14.8%; P ≤ .001), a difference that diminished with 3D TEE (1.4%; P = .41). The benefit of access to 3D information for MVP localization was greater for inexperienced echocardiographers compared with experts (P < .001).
CONCLUSIONS: The reported diagnostic advantage of 3D TEE over 2D TEE in MVP assessment for expert echocardiographers can be transferred to inexperienced echocardiographers. Inexperienced echocardiographers benefit from the technology to a greater extent than their expert colleagues.
Copyright © 2013 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  2D; 3D; ChR; Education; Experience; MV; MVP; Mitral valve; Mitral valve prolapse; Mitral valve prolapse assessment; Ruptured chordae tendineae; TEE; Three-dimensional; Three-dimensional transesophageal echocardiography; Training; Transesophageal echocardiography; Two-dimensional

Mesh:

Year:  2013        PMID: 23706343     DOI: 10.1016/j.echo.2013.04.015

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

Review 1.  Incremental value of 3-D transesophageal echocardiographic imaging of the mitral valve.

Authors:  Sonia Jain; Joseph F Malouf
Journal:  Curr Cardiol Rep       Date:  2014-01       Impact factor: 2.931

2.  The role of experience in echocardiographic identification of location and extent of mitral valve prolapse with 2D and 3D echocardiography.

Authors:  Lotte E de Groot-de Laat; Ben Ren; Jacky McGhie; Frans B S Oei; Mihai Strachinaru; Sharon W M Kirschbaum; Sakir Akin; Chris M Kievit; Ad J J C Bogers; Marcel L Geleijnse
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-11       Impact factor: 2.357

Review 3.  Three-Dimensional Echocardiography: Advancements in Qualitative and Quantitative Analyses of Mitral Valve Morphology in Mitral Valve Prolapse.

Authors:  Paola Gripari; Manuela Muratori; Laura Fusini; Gloria Tamborini; Mauro Pepi
Journal:  J Cardiovasc Echogr       Date:  2014 Jan-Mar

4.  Differences in echocardiography interpretation techniques among trainees and expert readers.

Authors:  David Roy Anderson; Sarah Blissett; Patricia O'Sullivan; Atif Qasim
Journal:  J Echocardiogr       Date:  2021-05-29

5.  Segmentation of Tricuspid Valve Leaflets From Transthoracic 3D Echocardiograms of Children With Hypoplastic Left Heart Syndrome Using Deep Learning.

Authors:  Christian Herz; Danielle F Pace; Hannah H Nam; Andras Lasso; Patrick Dinh; Maura Flynn; Alana Cianciulli; Polina Golland; Matthew A Jolley
Journal:  Front Cardiovasc Med       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.